Progressive growth of a small gallbladder polyp diagnosed as intracholecystic papillary neoplasm: a case report Authors: Yusaku Yokotani, Yuki Nakahata, Haruka Okuyama, Rieko Mukai, Junji Nagano, Naoyuki Sakamoto, Akihiro Obora, Yoshiki Murakami, Takao Kojima, Nobuaki Yagi Published: 2026 ABSTRACT Intracholecystic papillary neoplasm (ICPN) is a rare premalignant lesion of the gallbladder, and its natural history remains incompletely understood. We report a case of ICPN presenting as a small gallbladder polyp with progressive growth. A 56-year-old woman was found to have a gallbladder polyp measuring 7.6 mm, which increased to 11.2 mm over 2 years and 8 months. Contrast-enhanced computed tomography demonstrated a papillary lesion with enhancement. Laparoscopic cholecystectomy was performed. Histopathological examination revealed pyloric gland-type ICPN with low-grade dysplasia without invasive carcinoma. Immunohistochemical analysis showed positivity for MUC6 and MUC5AC, supporting gastric-type differentiation. No recurrence has been observed during postoperative follow-up.This case suggests that progressive growth, papillary morphology, and enhancement characteristics may indicate neoplastic potential even in gallbladder polyps initially measuring < 10 mm, suggesting the importance of careful follow-up and timely surgical intervention. Background Intracholecystic papillary neoplasm (ICPN) is an adenomatous papillary or polypoid epithelial tumor arising in the gallbladder, and it was newly classified as a precancerous lesion of gallbladder cancer in the 2010 WHO classification [1, 2]. ICPN typically presents as a localized intraluminal mass and shares morphological characteristics with intraductal papillary mucinous neoplasms (IPMN) of the pancreas and intraductal papillary neoplasms (IPNB) of the bile duct [1, 3]. The reported incidence of ICPN in cholecystectomy specimens remains relatively low, ranging from 0.4% to 1.5% [1, 4, 5]. Consequently, the clinical characteristics and natural history of ICPN have not yet been fully elucidated. ICPN is classified into several mucinous phenotypes, including biliary, gastric, intestinal, and pyloric gland types. Among these, the pyloric gland type is the most common subtype and is characterized by positivity for MUC6 [1, 6, 7]. It is generally considered to exhibit relatively low malignant potential. However, ICPN as a whole demonstrates heterogeneous clinicopathological features, and up to 55% of cases may coexist with invasive carcinoma [1, 8]. Despite this, non-invasive lesions show significantly better outcomes than conventional gallbladder carcinoma, and ICPN is considered to follow a distinct carcinogenic pathway [6, 8]. In the management of gallbladder polyps, lesion size has traditionally been used as an important criterion for surgical indication. However, tumor growth and contrast enhancement on CT imaging have also been reported as predictors of malignancy [9]. In particular, enlargement of the lesion raises concern for neoplastic or malignant potential, and the criteria for observation and surgical resection remain under active discussion internationally [9, 10]. Here, we report a case in which serial medical check-ups revealed progressive enlargement of a gallbladder polyp, and surgical resection demonstrated pyloric gland-type ICPN with low-grade dysplasia. Case presentation A 56-year-old woman was referred to our department for further inspection of a gallbladder polyp, which was detected by abdominal ultrasound (AUS) during a medical check-up at our hospital. She had a medical history of dyslipidemia and was taking pitavastatin. She had no personal or family history of malignancy. There were no symptoms, and the blood test showed no abnormal findings, including tumor markers. The first examination of AUS showed an irregular papillary mass measuring up to 7.6 mm in the gallbladder fundus. Because the thickening and inflammation of the gallbladder wall were not found, and the patient was asymptomatic, regular follow-up was planned. Follow-up ultrasonography was performed approximately every 6 months. After several check-ups, at the ultrasonographic examination performed 2 years and 8 months later, the mass had increased in size to 11.2 mm (Fig. 1). Fig. 1Serial ultrasonographic findings of the gallbladder polyp. The lesion initially measured approximately 7.6 mm (A) and gradually increased in size over time (B: 6 months later, C: 1 year later, D: 1 year and 6 months later, E: 2 years later), reaching 11.2 mm at 2 years and 8 months (F) Serial ultrasonographic findings of the gallbladder polyp. The lesion initially measured approximately 7.6 mm (A) and gradually increased in size over time (B: 6 months later, C: 1 year later, D: 1 year and 6 months later, E: 2 years later), reaching 11.2 mm at 2 years and 8 months (F) Although contrast-enhanced computed tomography (CECT) imaging showed no obvious invasion of the lesion into adjacent organs, the lesion was visualized as an irregular papillary structure with contrast enhancement (Fig. 2). Additionally, lymph node metastasis, metastasis to solid organs, and peritoneal dissemination were not observed. MRCP showed no abnormalities (Fig. 2). Fig. 2Radiological findings. A: Contrast-enhanced computed tomography (CECT) showing a papillary protruding lesion in the gallbladder with early-phase enhancement. B: Magnetic resonance cholangiopancreatography (MRCP) demonstrating no biliary tract abnormalities Radiological findings. A: Contrast-enhanced computed tomography (CECT) showing a papillary protruding lesion in the gallbladder with early-phase enhancement. B: Magnetic resonance cholangiopancreatography (MRCP) demonstrating no biliary tract abnormalities Surgery was considered because the lesion had increased in size and exceeded 10 mm; the possibility of a malignant lesion was considered. Laparoscopic cholecystectomy was performed, and the patient was discharged with no complications. Macroscopically, the resected gallbladder specimen demonstrated a sessile papillary lesion measuring 12 × 8 mm in the gallbladder fundus (Fig. 3). Fig. 3Macroscopic and histopathological findings. A: Resected gallbladder specimen showing a sessile papillary lesion measuring 12 × 8 mm protruding into the lumen. B, C: Hematoxylin and eosin staining demonstrating papillary and tubular proliferation of epithelial cells. Background gallbladder mucosa shows mild inflammatory cell infiltration. D: Immunohistochemistry demonstrating a wild-type p53 staining pattern without diffuse strong nuclear overexpression. E: Immunohistochemical staining of β-catenin showing membranous positivity with focal nuclear accumulation in tumor cells Macroscopic and histopathological findings. A: Resected gallbladder specimen showing a sessile papillary lesion measuring 12 × 8 mm protruding into the lumen. B, C: Hematoxylin and eosin staining demonstrating papillary and tubular proliferation of epithelial cells. Background gallbladder mucosa shows mild inflammatory cell infiltration. D: Immunohistochemistry demonstrating a wild-type p53 staining pattern without diffuse strong nuclear overexpression. E: Immunohistochemical staining of β-catenin showing membranous positivity with focal nuclear accumulation in tumor cells Histologically, the lesion showed papillary and tubular proliferation of epithelial cells corresponding to the grossly identified lesion. Focal pyloric gland metaplasia was observed within the lesion. The lesion was entirely submitted for histological examination. Although extension into Rokitansky–Aschoff sinuses was observed, no definite stromal invasion or desmoplastic reaction was identified, and no invasive carcinoma was identified. The cystic duct margin was free of neoplasia. Immunohistochemically, p53 demonstrated a wild-type staining pattern without diffuse strong nuclear overexpression. β-catenin staining showed membranous positivity with focal nuclear accumulation in tumor cells. AE1/AE3 showed diffuse positivity, confirming the epithelial nature of the lesion (Fig. 4). The tumor cells were positive for MUC6 and MUC5AC, supporting gastric-type differentiation, particularly pyloric gland-type ICPN. MUC2-positive cells were only focally observed, whereas MUC1 showed faint staining overall with focal strong positivity. CDX2 was negative (Fig. 4). Fig. 4Immunohistochemical findings. MUC2 (A) and CDX2 (B) were negative, while AE1/AE3 (C), MUC5AC (E), and MUC6 (F) were positive. MUC1 staining showing no significant immunoreactivity in the tumor cells (D) Immunohistochemical findings. MUC2 (A) and CDX2 (B) were negative, while AE1/AE3 (C), MUC5AC (E), and MUC6 (F) were positive. MUC1 staining showing no significant immunoreactivity in the tumor cells (D) Histologically, the lesion predominantly demonstrated relatively uniform tubular to focal papillary proliferation without marked nuclear pleomorphism, necrosis, or definite cribriform architecture. Immunohistochemically, p53 showed a wild-type staining pattern without diffuse strong nuclear overexpression, and the Ki-67 labeling index was approximately 20%. Taken together, these findings were considered insufficient to support a diagnosis of high-grade dysplasia, and the lesion was therefore classified as pyloric gland-type ICPN with low-grade dysplasia according to the WHO classification. Postoperative follow-up with CECT has been performed every 6 months, similar to surveillance protocols for gallbladder carcinoma, and no evidence of recurrence has been observed to date (Table 1). Table 1Clinical timeline of the present caseTime pointFindings / InterventionInitial examinationAUS detected a 7.6 mm irregular papillary gallbladder polyp.6 monthsThe lesion was 8.1 mm in diameter.1 yearNo obvious growth was observed (8.2 mm in diameter).1 year 6 monthsNo obvious growth was observed (8.0 mm in diameter).2 yearsLesion size slightly increased (8.6 mm in diameter).2 years 8 monthsLesion enlarged to 11.2 mm.Preoperative evaluationCECT demonstrated enhancement of the papillary lesion; MRCP showed no biliary abnormalities.SurgeryLaparoscopic cholecystectomy was performed.HistopathologySurgical specimen showed pyloric gland-type ICPN with focal high-grade dysplasia without invasion.Postoperative follow-upFollow-up CECT every 6 months has been performed with no recurrence to date.Summary of the serial imaging findings, lesion size progression, diagnostic workup, surgical intervention, histopathological diagnosis, and postoperative follow-up of the gallbladder polyp diagnosed as intracholecystic papillary neoplasm (ICPN) Table 1Clinical timeline of the present caseTime pointFindings / InterventionInitial examinationAUS detected a 7.6 mm irregular papillary gallbladder polyp.6 monthsThe lesion was 8.1 mm in diameter.1 yearNo obvious growth was observed (8.2 mm in diameter).1 year 6 monthsNo obvious growth was observed (8.0 mm in diameter).2 yearsLesion size slightly increased (8.6 mm in diameter).2 years 8 monthsLesion enlarged to 11.2 mm.Preoperative evaluationCECT demonstrated enhancement of the papillary lesion; MRCP showed no biliary abnormalities.SurgeryLaparoscopic cholecystectomy was performed.HistopathologySurgical specimen showed pyloric gland-type ICPN with focal high-grade dysplasia without invasion.Postoperative follow-upFollow-up CECT every 6 months has been performed with no recurrence to date.Summary of the serial imaging findings, lesion size progression, diagnostic workup, surgical intervention, histopathological diagnosis, and postoperative follow-up of the gallbladder polyp diagnosed as intracholecystic papillary neoplasm (ICPN) Clinical timeline of the present case Summary of the serial imaging findings, lesion size progression, diagnostic workup, surgical intervention, histopathological diagnosis, and postoperative follow-up of the gallbladder polyp diagnosed as intracholecystic papillary neoplasm (ICPN) Discussion and conclusions In this case, the patient underwent a laparoscopic cholecystectomy, despite the absence of symptoms. In asymptomatic patients, the indication for surgical intervention is often controversial, and patients may be reluctant to undergo invasive procedures. Therefore, establishing appropriate criteria for recommending surgery in gallbladder polyps is essential. This is particularly important because gallbladder cancer is associated with a poor prognosis, with a 5-year survival rate of less than 25% in advanced stages [11, 12]. Thus, appropriate surveillance and timely intervention are critical in clinical practice. Although it represents a single case report, and long-term follow-up data are not available, this case provides a rationale that growth dynamics, rather than size alone, should be considered when evaluating the malignant potential of gallbladder polyps. The etiology of ICPN remains incompletely defined, and the epidemiologic risk factors have not been established. Although referring to the previous report, ICPN was found in the background of cholesterolosis, the relation between ICPN and cholesterolosis is still unclear [13]. ICPN is defined as a grossly visible intraluminal epithelial neoplasm with papillary and/or tubular architecture, exhibiting a spectrum of dysplasia from low to high grade with the possibility of malignancy [1, 2, 4]. In contrast, most gallbladder polypoid lesions detected on transabdominal ultrasonography are non-neoplastic (e.g., cholesterol polyps), and the overall prevalence of malignancy among ultrasound-detected gallbladder polyps is low. In a systematic review including 5,482 gallbladder polyps, malignant polyps accounted for 0.57% of cases [14]. Consistently, a large population-based cohort study reported that gallbladder cancer was rare among individuals with polyps, with an overall incidence of 11.3 per 100,000 person-years, and 3.6 per 100,000 person-years among those followed for ≥ 1 year [15]. Risk stratification is primarily size-driven; a meta-analysis modeling malignancy risk across incremental polyp sizes concluded that malignant risk is particularly low in polyps < 10 mm, supporting contemporary guideline thresholds that recommend cholecystectomy mainly for lesions ≥ 10 mm [9]. In addition, interval growth during surveillance is considered an important risk factor supporting surgical intervention [10]. In the present case, the lesion initially measured less than 10 mm but demonstrated progressive enlargement during serial ultrasonographic follow-up and eventually exceeded the 10-mm threshold. Therefore, the decision to perform a cholecystectomy was considered consistent with current international recommendations. ICPN is a distinct preinvasive neoplasm of the gallbladder and carries a substantially higher likelihood of harboring or being associated with invasive carcinoma compared with common gallbladder polyps. In a landmark multi-institutional clinicopathologic study proposing the unified ICPN concept, 55% of ICPNs were associated with invasive carcinoma [16]. Similar invasion rates have been reported in other series [17]. Thus, unlike most small incidental gallbladder polyps, ICPN is clinically important because it frequently coexists with invasion at diagnosis, and management should reflect this higher malignant potential [16, 17]. Recent pooled analyses have demonstrated that approximately 35% of ICPNs harbor high-grade dysplasia and nearly 27% are associated with invasive adenocarcinoma, highlighting their substantial malignant potential [5]. Current pathological frameworks propose at least two major pathways for gallbladder carcinogenesis: a papillary (polypoid) pathway, represented by ICPN, and a flat dysplasia pathway, represented by biliary intraepithelial neoplasia [7]. Comparative outcome studies have shown that invasive gallbladder carcinomas associated with ICPN demonstrate a more favorable prognosis than those arising without a papillary precursor, supporting the concept that ICPN-associated carcinogenesis represents a biologically distinct pathway [6, 8]. Currently, ultrasonography, computed tomography, and magnetic resonance imaging are the primary imaging modalities for identifying ICPN. Ultrasonography is useful for detecting polypoid or mass-forming lesions within the gallbladder and for evaluating their size, anatomical distribution, and morphological characteristics. CECT plays an important role in assessing the depth of local tumor infiltration as well as the presence of regional lymph node involvement or distant metastatic disease. According to the previous article, gallbladder polyps that are well visualized on computed tomography may be more likely to represent neoplastic lesions. Additionally, neoplastic gallbladder polyps tend to demonstrate arterial-phase enhancement, reflecting increased vascularity, whereas non-neoplastic lesions, such as cholesterol polyps, are often poorly visualized on CT [18]. However, the available evidence remains limited, and no standardized or widely accepted imaging criteria based on CT enhancement patterns have yet been established. For abdominal ultrasonography, ICPN is most often visualized as a sessile papillary mass lesion with isoechoic to hypoechoic echogenicity [1, 6, 9]; however, these imaging findings are nonspecific, making a preoperative diagnosis of ICPN difficult. ICPNs are further subclassified by epithelial lineage and mucin expression profile, including pyloric (gastric), biliary, intestinal, and foveolar types [1, 3, 8]. Among these, the pyloric gland type, as observed in the present case, is the most common subtype and is typically characterized by strong MUC6 expression, reflecting pyloric gland differentiation. MUC5AC expression may also be observed in gastric-type lesions, particularly in the foveolar subtype, whereas intestinal-type ICPNs frequently express CDX2. These immunophenotypic features help distinguish lineage differentiation and understanding tumor biology [1, 3, 8]. In addition, nuclear or cytoplasmic β-catenin expression is frequently observed in gastric/pyloric-type ICPN, correlating with the alterations in the Wnt/β-catenin pathway, while p53 overexpression is more commonly seen in invasive lesions, supporting a role for IHC in both phenotypic classification and risk stratification [19, 20]. In the present case, the tumor cells showed positivity for MUC6 and MUC5AC, supporting gastric-type differentiation. All the findings of IHC were consistent with pyloric gland-type ICPN. In addition, focal nuclear accumulation of β-catenin, as observed in the present case, may suggest activation of the Wnt/β-catenin signaling pathway, which has been implicated in the tumorigenesis of gastric/pyloric-type ICPN [19, 20]. In conclusion, this case underscores the clinical significance of careful follow-up of gallbladder polyps, even when they are initially small. Previous reports describing ICPN arising from small gallbladder polyps under longitudinal surveillance are limited. Koike et al. reported a rare case of ICPN in which a small sessile gallbladder polyp was followed by ultrasonography and enlarged to approximately 10 mm before resection [21]. Similarly, the present case demonstrated progressive enlargement of a small gallbladder polyp during serial ultrasonographic follow-up. These cases suggest that interval growth, rather than initial size alone, may be clinically relevant when evaluating small gallbladder polyps. Early surgical intervention based on serial imaging changes may allow complete resection at a non-invasive stage and contribute to favorable clinical outcomes. A thorough understanding of the clinical and pathological features of ICPN is essential for appropriate diagnosis and management. This knowledge regarding ICPN should be shared broadly with gastroenterologists, as the management of gallbladder polyps is clinically important.